Accendra Health, Inc.
ACH Healthcare Medical Distribution
In the quarter to June 2026, revenue fell 10.1%, EPS grew 89.7%, free cash flow fell 1,624.8% and total debt fell 13.1%, each against the same quarter a year earlier.
Follow ACH
Accendra Health, Inc. (ACH) Altman Z-score
Accendra Health, Inc.'s Altman Z-score for fiscal 2025 is 0.40, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 0.40 | (0.23) |
| FY2024 | 0.62 | (0.33) |
| FY2023 | 0.95 | (1.45) |
| FY2022 | 2.40 | (1.93) |
| FY2021 | 4.33 | 0.84 |
| FY2020 | 3.49 | 0.46 |
| FY2019 | 3.03 | 0.36 |
| FY2018 | 2.67 | (1.06) |
| FY2017 | 3.73 | (1.59) |
| FY2016 | 5.32 | 0.05 |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (0.16) | — | −0.20 | |
| Retained earnings / total assets | (0.44) | — | −0.62 | |
| EBIT / total assets | 0.01 | — | 0.04 | |
| Market value of equity / total liabilities | 0.07 | — | 0.04 | |
| Sales / total assets | 1.13 | — | 1.13 | |
| Altman Z-score | Distress zone | 0.40 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −2.59 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| AHG Akso Health Group Sponsored ADR compare | 113× |
| CAH Cardinal Health, Inc. compare | 5.1× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 3.4× |
| YI 111, Inc. Sponsored ADR compare | 3.3× |
| HSIC Henry Schein, Inc. compare | 2.7× |
| ACH Accendra Health, Inc. | 0.4× |
| FOCL FocalTherics compare | −0.9× |
| COSM Cosmos Health Inc. compare | −2.5× |
| SNYRQ Synergy CHC Corp. compare | −7.0× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets